A detailed history of Ronald Blue Trust, Inc. transactions in Enovis Corp stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 195 shares of ENOV stock, worth $8,880. This represents 0.0% of its overall portfolio holdings.

Number of Shares
195
Previous 13 1400.0%
Holding current value
$8,880
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$40.57 - $48.1 $7,383 - $8,754
182 Added 1400.0%
195 $8,000
Q2 2024

Jul 18, 2024

BUY
$44.56 - $62.43 $579 - $811
13 New
13 $0
Q4 2023

Jan 18, 2024

BUY
$43.67 - $57.07 $786 - $1,027
18 New
18 $1,000
Q2 2023

Jul 14, 2023

SELL
$52.7 - $64.12 $2,529 - $3,077
-48 Reduced 94.12%
3 $0
Q1 2023

Apr 17, 2023

BUY
$49.5 - $65.92 $2,524 - $3,361
51 New
51 $3,000
Q2 2022

Aug 09, 2022

BUY
$55.0 - $70.47 $2,365 - $3,030
43 New
43 $2,000

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $2.47B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.